Your browser doesn't support javascript.
loading
[Haemostasis. Aspirin and clopidogrel platelet resistances]. / Hémostase. Résistances plaquettaires à l'aspirine et au clopidogrel.
Fontana, P; Berdagué, P; Reny, J L.
  • Fontana P; Service d'angiologie et d'hémostase, Département de médecine interne, Faculté de médecine et HUG, 1211 Genève 14. pierre.fontana@medecine.unige.ch
Rev Med Suisse ; 2(47): 25-9, 2006 Jan 04.
Article en Fr | MEDLINE | ID: mdl-16465941
ABSTRACT
Articles on antiplatelet "resistance" or "nonresponder" subjects now appear in the medical literature or in the media on a regular basis. The clinical consequences of such biological resistances are yet uncertain. In this review, we describe the concepts of specific and non specific resistances according to the tests used and summarize the main studies up to now. If antiplatelet drug resistances are shown to be predictive of cardiovascular events in large prospective studies, tailoring antiplatelet drugs could be beneficial and, therefore, warranted. New compounds with a more potent effect are emerging and might be useful in clinically relevant resistances.
Asunto(s)
Search on Google
Banco de datos: MEDLINE Asunto principal: Ticlopidina / Inhibidores de Agregación Plaquetaria / Aspirina / Hemostasis Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: Fr Año: 2006 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Ticlopidina / Inhibidores de Agregación Plaquetaria / Aspirina / Hemostasis Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: Fr Año: 2006 Tipo del documento: Article